Double Hematological and Cardiologic Benefits of Autologous Stem Cell Transplantation in a Case of stage III B IgG Myeloma multiplex and Dilatative Cardiomyopathy – a Case Report

1. Hoffmann R., Benz E.J.Jr. & Silberstein L.E. (2013). Hematology: basic principles and practice. (pp 1328-1334). Elsevier Saunders. Philadelphia, PA, USA.Search in Google Scholar

2. The EBMT (2008). ESH Handbook Haematopoietic Stem Cell Transplantation (pp 112-128), from http://ebmtonline.forumservice.net/Search in Google Scholar

3. Zver S1., Zadnik V., Cernelc P. & Kozelj M. (2008). Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation. Int J Hematol. 88(2),227-36. doi: 10.1007/s12185-008-0112-510.1007/s12185-008-0112-518548196Search in Google Scholar

4. Garbenn J.C. & Lee R.T. (2013). Cardiac Stem Cell Therapy and The Promise of Heart regeneration. Cell Stem Cell. 12(6),689-98. doi: 10.1016/j.stem.2013.05.008.10.1016/j.stem.2013.05.008375630923746978Search in Google Scholar